NEO
NeoGenomics IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$1.07B
P/E Ratio
—
EPS
$-0.84
Beta
1.71
52W High
$13.74
52W Low
$4.72
50-Day MA
$9.66
200-Day MA
$9.31
Dividend Yield
—
Profit Margin
-14.80%
Forward P/E
222.22
PEG Ratio
2.09
About NeoGenomics Inc
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
Fundamentals
| Revenue (TTM) | $727.33M |
| Gross Profit (TTM) | $313.89M |
| EBITDA | $-1.82M |
| Operating Margin | -6.56% |
| Return on Equity | -12.40% |
| Return on Assets | -2.90% |
| Revenue/Share (TTM) | $5.68 |
| Book Value | $6.49 |
| Price-to-Book | 1.24 |
| Price-to-Sales (TTM) | 1.47 |
| EV/Revenue | 1.77 |
| EV/EBITDA | -27.92 |
| Quarterly Earnings Growth (YoY) | 130.60% |
| Quarterly Revenue Growth (YoY) | 10.60% |
| Shares Outstanding | $130.14M |
| Float | $119.20M |
| % Insiders | 1.46% |
| % Institutions | 102.57% |
Historical Volatility
HV 10-Day
52.86%
HV 20-Day
52.07%
HV 30-Day
49.19%
HV 60-Day
48.10%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($14.81 target)
2
Strong Buy4
Buy7
HoldData last updated: 4/9/2026